151 related articles for article (PubMed ID: 2935745)
21. Acetylcholine content and distribution in rat cortical synaptosomes after in vivo exposure to quinolinic acid.
Metcalf RH; Riddell DL; Boegman RJ
Neurosci Lett; 1990 Jan; 108(1-2):219-24. PubMed ID: 2137564
[TBL] [Abstract][Full Text] [Related]
22. Neurotensin regulation of endogenous acetylcholine release from rat cerebral cortex: effect of quinolinic acid lesions of the basal forebrain.
Lapchak PA; Araujo DM; Quirion R; Beaudet A
J Neurochem; 1990 Oct; 55(4):1397-403. PubMed ID: 2144584
[TBL] [Abstract][Full Text] [Related]
23. The response of striatal neuropeptide Y and cholinergic neurons to excitatory amino acid agonists.
Boegman RJ; Parent A
Brain Res; 1988 Jun; 452(1-2):219-26. PubMed ID: 2900050
[TBL] [Abstract][Full Text] [Related]
24. Further characterizations of the nature of the behavioral and neurochemical effects of lesions to the nucleus basalis of Meynert in the rat.
Altman HJ; Crosland RD; Jenden DJ; Berman RF
Neurobiol Aging; 1985; 6(2):125-30. PubMed ID: 4022231
[TBL] [Abstract][Full Text] [Related]
25. Lesions of the nucleus basalis magnocellularis in the rat: morphological, biochemical and behavioral reparative effect of nerve growth factor and ganglioside GM1.
Casamenti F; Milan F; Pepeu G
Acta Neurobiol Exp (Wars); 1990; 50(4-5):461-73. PubMed ID: 2130662
[TBL] [Abstract][Full Text] [Related]
26. Stimulation of the nucleus basalis of Meynert increases acetylcholine release in the cerebral cortex in rats.
Kurosawa M; Sato A; Sato Y
Neurosci Lett; 1989 Mar; 98(1):45-50. PubMed ID: 2565563
[TBL] [Abstract][Full Text] [Related]
27. Partial reversal of lesion-induced deficits in cortical cholinergic markers by nerve growth factor.
Haroutunian V; Kanof PD; Davis KL
Brain Res; 1986 Oct; 386(1-2):397-9. PubMed ID: 3779417
[TBL] [Abstract][Full Text] [Related]
28. Nerve growth factor promotes survival of cultured magnocellular cholinergic neurons from nucleus basalis of Meynert in postnatal rats.
Hatanaka H; Nihonmatsu I; Tsukui H
Neurosci Lett; 1988 Jul; 90(1-2):63-8. PubMed ID: 2842704
[TBL] [Abstract][Full Text] [Related]
29. Kynurenic acid antagonizes hippocampal quinolinic acid neurotoxicity: behavioral and histological evaluation.
Lekieffre D; Plotkine M; Allix M; Boulu RG
Neurosci Lett; 1990 Nov; 120(1):31-3. PubMed ID: 2149878
[TBL] [Abstract][Full Text] [Related]
30. Rivastigmine antagonizes deficits in prepulse inhibition induced by selective immunolesioning of cholinergic neurons in nucleus basalis magnocellularis.
Ballmaier M; Casamenti F; Scali C; Mazzoncini R; Zoli M; Pepeu G; Spano PF
Neuroscience; 2002; 114(1):91-8. PubMed ID: 12207957
[TBL] [Abstract][Full Text] [Related]
31. GM1 ganglioside protects nucleus basalis from excitotoxin damage: reduced cortical cholinergic losses and animal mortality.
Mahadik SP; Vilim F; Korenovsky A; Karpiak SE
J Neurosci Res; 1988 Aug; 20(4):479-83. PubMed ID: 3184210
[TBL] [Abstract][Full Text] [Related]
32. Cortical muscarinic receptor function following quinolinic acid-induced lesion of the nucleus basalis magnocellularis.
Scarth BJ; Jhamandas K; Boegman RJ; Beninger RJ; Reynolds JN
Exp Neurol; 1989 Feb; 103(2):158-64. PubMed ID: 2912759
[TBL] [Abstract][Full Text] [Related]
33. Serotonergic input to cholinergic neurons in the substantia innominata and nucleus basalis magnocellularis in the rat.
Gasbarri A; Sulli A; Pacitti C; McGaugh JL
Neuroscience; 1999; 91(3):1129-42. PubMed ID: 10391489
[TBL] [Abstract][Full Text] [Related]
34. Preservation of cholinergic activity and prevention of neuron death by CEP-1347/KT-7515 following excitotoxic injury of the nucleus basalis magnocellularis.
Saporito MS; Brown ER; Carswell S; DiCamillo AM; Miller MS; Murakata C; Neff NT; Vaught JL; Haun FA
Neuroscience; 1998 Sep; 86(2):461-72. PubMed ID: 9881861
[TBL] [Abstract][Full Text] [Related]
35. Differential alterations of cortical cholinergic and neurotensin markers following ibotenic acid lesions of the nucleus basalis magnocellularis.
Lapchak PA; Araujo DM; Pasinetti G; Hefti F
Brain Res; 1993 Jun; 613(2):239-46. PubMed ID: 8186970
[TBL] [Abstract][Full Text] [Related]
36. 17beta-estradiol enhances cortical cholinergic innervation and preserves synaptic density following excitotoxic lesions to the rat nucleus basalis magnocellularis.
Horvath KM; Hårtig W; Van der Veen R; Keijser JN; Mulder J; Ziegert M; Van der Zee EA; Harkany T; Luiten PG
Neuroscience; 2002; 110(3):489-504. PubMed ID: 11906788
[TBL] [Abstract][Full Text] [Related]
37. Neurochemical effects following AF64A injection into the basal nuclei of rats.
Yoshimura K; Yamashita M; Okano T; Ikeda H
Jpn J Psychiatry Neurol; 1987 Dec; 41(4):755-62. PubMed ID: 3453422
[TBL] [Abstract][Full Text] [Related]
38. Differential action of NMDA antagonists on cholinergic neurotoxicity produced by N-methyl-D-aspartate and quinolinic acid.
Pawley AC; Flesher S; Boegman RJ; Beninger RJ; Jhamandas KH
Br J Pharmacol; 1996 Mar; 117(6):1059-64. PubMed ID: 8882597
[TBL] [Abstract][Full Text] [Related]
39. Nucleus basalis magnocellularis lesions: lack of biochemical and immunocytochemical recovery and effect of cholinesterase inhibitors on passive avoidance.
Thal LJ; Dokla CP; Armstrong DM
Behav Neurosci; 1988 Dec; 102(6):852-60. PubMed ID: 3214535
[TBL] [Abstract][Full Text] [Related]
40. Choline acetyltransferase activity associated with cerebral cortical microvessels does not originate in basal forebrain neurons.
Galea E; Fernández-Shaw C; Triguero D; Estrada C
J Cereb Blood Flow Metab; 1991 Sep; 11(5):875-8. PubMed ID: 1874821
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
